Quantum Computing is trading 5.13% higher at $6.70, partly reversing its recent decline; no clear company-specific catalyst for the October 15 gain emerged in available reports. - The company announced an INmune Bio research collaboration on October 14; a Rosenblatt-hosted management event was scheduled for October 15. Available sources do not connect either to the move. - Software stocks are under pressure; Reuters reported inflation-driven rate concerns weighing on technology shares. Supplied market context shows major U.S. indexes modestly higher.